Impact of human sequences in variable domains of therapeutic antibodies on the location of CD4 T-cell epitopes
federal regulators to make a decision on whether to approve orforglipron for obesity as soon as this spring
The GLP-1s that were originally marketed as a diabetes treatment include semaglutide, brand name Ozempic, liraglutide, brand name Victoza, dulaglutide, brand name Trulicity, and the latest GLP-1 to the market, tirzepitide, brand name Mounjaro, which is a combination GIP/GLP-1
[DOI] [PubMed] [Google Scholar] 57.Smith C., Woessner M.N., Sim M., Levinger I
When the cell naturally sheds, this stored iron is lost from the body
While it is unclear what Lilly will do in light of this development, we expect some if not most compounders will see this as an opportunity for at least temporarily continuing to compound tirzepatide